• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXPRESS LD VASCULAR; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXPRESS LD VASCULAR; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number 20212
Device Problems Premature Activation (1484); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/09/2023
Event Type  malfunction  
Manufacturer Narrative
E1: initial reporter phone: (b)(6).Device analysis: a visual examination of the returned device confirmed that the balloon was tightly wrapped and had not been subjected to positive pressure.Visual examination also revealed that the stent was positioned in the correct location on the balloon with no evidence of damage or any other issues noted.During analysis, the investigator successfully advanced the device through an 7f boston scientific guide sheath without any resistance or issues noted.No other issues were noted during product analysis.
 
Event Description
It was reported that stent partial deployment occurred.The 70% stenosed target lesion was located in the non-tortuous and mildly calcified subclavian artery.A 9.0x30x135 cm express ld vascular stent was used.During the delivery of the stent, the physician encountered resistance between the delivery system and the unknown vascular sheath.The resistance intensified as the physician continued to advance, and the stent was partially deployed prior to reaching the target lesion.The stent and delivery system were removed, and the procedure was completed with another of the same device.There were no complications reported and the patient is stable.
 
Manufacturer Narrative
E1: initial reporter phone: (b)(6).Device evaluated by mfr.: an express ld device was received for analysis.The recommended introducer sheath size for this express ld device is an 7fr.During analysis the investigator successfully advanced the device through an 7fr boston scientific guide without any resistance or issues noted.The guide used by the customer was not returned for analysis.A visual examination of the returned device confirmed that the balloon was tightly wrapped and had not been subjected to positive pressure.No issues were noted with the balloon material.A visual examination found the stent positioned in the correct location on the balloon with no evidence of damage or any other issues noted.No issues were noted with the tip of the device.
 
Event Description
It was reported that stent partial deployment occurred.The 70% stenosed target lesion was located in the non-tortuous and mildly calcified subclavian artery.A 9.0x30x135 cm express ld vascular stent was used.During the delivery of the stent, the physician encountered resistance between the delivery system and the unknown vascular sheath.The resistance intensified as the physician continued to advance, and the stent was partially deployed prior to reaching the target lesion.The stent and delivery system were removed, and the procedure was completed with another of the same device.There were no complications reported and the patient is stable.It was further reported that the stent system was pulled out as a whole without using other devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS LD VASCULAR
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17209542
MDR Text Key317941060
Report Number2124215-2023-32077
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number20212
Device Catalogue Number20212
Device Lot Number0029975899
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/08/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/28/2023
Initial Date FDA Received06/27/2023
Supplement Dates Manufacturer Received06/21/2023
Supplement Dates FDA Received07/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age54 YR
Patient SexMale
Patient Weight60 KG
-
-